Early involvement of gut is observed in Parkinson's disease (PD) and symptoms such as
constipation may precede motor symptoms. α-Synuclein pathology is extensively evident in …

Parkinson's Disease (PD) is currently considered a systemic neurodegenerative disease
manifested with not only motor but also non-motor symptoms. In particular, weight loss and …

Gut microbiota of patients with Parkinson's disease and healthy volunteers was analyzed by
the method of high throughput 16S rRNA sequencing of bacterial genomes. In patients with …

Parkinson's disease (PD) exhibits systemic effects on the human metabolism, with emerging
roles for the gut microbiome. Here, we integrate longitudinal metabolome data from 30 drug …

Neuroendocrine abnormalities are common in Parkinson's disease (PD) and include
disruption of melatonin secretion, disturbances of glucose, insulin resistance and bone …

Importance Greater body mass index (BMI, calculated as weight in kilograms divided by
height in meters squared) is associated with improved survival among persons with …

Background Levodopa‐carbidopa intestinal gel (LCIG) is an established treatment for
improving motor and some non‐motor symptoms (NMS) in patients with advanced …

Lately, studies have shown that patients with Parkinson's disease (PD) report a strong
craving for sweets and consume significantly more fast-acting carbohydrates than healthy …

Unexplained weight changes that occur in Parkinson's disease (PD), are often neglected
and remain a poorly understood non-motor feature in patients with PD. A specific 'Park …

Introduction Although weight loss is common in Parkinson's disease (PD), longitudinal
studies assessing weight and body composition changes are limited. Methods In this three …